Biblio

Export 13 results:
Author [ Title(Desc)] Type Year
Filters: Author is Rissman, Robert A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
J. A. Soria, Huisa, B. N., Edland, S. D., Litvan, I., Peavy, G. M., Salmon, D. P., Hansen, L. A., Galasko, D. R., Brewer, J. B., González, H. M., and Rissman, R. A., “Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1539-1548, 2018.
D
S. Sokolow, Li, X., Chen, L., Taylor, K. D., Rotter, J. I., Rissman, R. A., Aisen, P. S., and Apostolova, L. G., “Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
E
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
G
C. N. Winston, Goetzl, E. J., Baker, L. D., Vitiello, M. V., and Rissman, R. A., “Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
O. Prikhodko, Rynearson, K. D., Sekhon, T., Mante, M. M., Nguyen, P. D., Rissman, R. A., Tanzi, R. E., and Wagner, S. L., “The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1541-1554, 2020.
I
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., “Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
N
C. N. Winston, Aulston, B., Rockenstein, E. M., Adame, A., Prikhodko, O., Dave, K. N., Mishra, P., Rissman, R. A., and Yuan, S. H., “Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.”, J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
P. Aguilar-Calvo, Sevillano, A. M., Rasool, S., Cao, K. J., Randolph, L. M., Rissman, R. A., Sarraf, S. T., Yang, J., and Sigurdson, C. J., “Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1137-1145, 2022.
P
M. S. Rafii, Lukic, A. S., Andrews, R. D., Brewer, J., Rissman, R. A., Strother, S. C., Wernick, M. N., Pennington, C., Mobley, W. C., Ness, S., and Matthews, D. C., “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
S. E. O'Bryant, Zhang, F., Johnson, L. A., Hall, J., Edwards, M., Grammas, P., Oh, E., Lyketsos, C. G., and Rissman, R. A., “A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 97-104, 2018.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
T
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.